Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes
- 1 March 2014
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (5), 1452-1462
- https://doi.org/10.1158/0008-5472.can-13-2171
Abstract
The underlying molecular pathogenesis in hepatocellular carcinoma remains poorly understood. The transcription factor MEF2D promotes survival in various cell types and it seems to function as an oncogene in leukemia. However, its potential contributions to solid cancers have not been explored. In this study, we investigated MEF2D expression and function in hepatocellular carcinoma, finding that MEF2D elevation in hepatocellular carcinoma clinical specimens was associated with poor prognosis. MEF2D-positive primary hepatocellular carcinoma cells displayed a faster proliferation rate compared with MEF2D-negative cells, and silencing or promoting MEF2D expression in these settings limited or accelerated cell proliferation, respectively. Notably, MEF2D-silencing abolished hepatocellular carcinoma tumorigenicity in mouse xenograft models. Mechanistic investigations revealed that MEF2D-silencing triggered G2–M arrest in a manner associated with direct downregulation of the cell-cycle regulatory genes RPRM, GADD45A, GADD45B, and CDKN1A. Furthermore, we identified MEF2D as an authentic target of miR-122, the reduced expression of which in hepatocellular carcinoma may be responsible for MEF2D upregulation. Together, our results identify MEF2D as a candidate oncogene in hepatocellular carcinoma and a potential target for hepatocellular carcinoma therapy. Cancer Res; 74(5); 1452–62. ©2014 AACR.Keywords
Other Versions
This publication has 44 references indexed in Scilit:
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaJournal of Hepatology, 2012
- Conflicting Roles of Molecules in Hepatocarcinogenesis: Paradigm or ParadoxCancer Cell, 2012
- Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cellsJournal of Hematology & Oncology, 2010
- Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated AutophagyScience, 2009
- Retinoic acid responsive genes in the murine hepatocyte cell line AML 12Gene, 2008
- The MEF2D transcription factor mediates stress-dependent cardiac remodeling in miceJCI Insight, 2008
- RNA Interference Reveals a Requirement for Myocyte Enhancer Factor 2A in Activity-dependent Neuronal SurvivalOnline Journal of Public Health Informatics, 2002
- New genes involved in cancer identified by retroviral taggingNature Genetics, 2002
- Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2Science, 1999